Spots Global Cancer Trial Database for ricolinostat
Every month we try and update this database with for ricolinostat cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Phase 1b Study Evaluating ACY-1215 (Ricolinostat) in Combination With Pomalidomide and Dexamethasone in Relapsed or Relapsed-and-Refractory Multiple Myeloma | NCT02189343 | Multiple Myelom... | ACY-1215 in com... | 18 Years - | Celgene | |
A Phase 1b Study of Paclitaxel And Ricolinostat For The Treatment Of Gynecological Cancer | NCT02661815 | Ovarian Cancer Fallopian Tube ... Primary Periton... | Paclitaxel Ricolinostat Bevacizumab | 18 Years - | Dana-Farber Cancer Institute | |
Ricolinostat, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable or Metastatic Cholangiocarcinoma | NCT02856568 | Non-Resectable ... Recurrent Chola... Stage III Extra... Stage III Intra... Stage IIIA Hila... Stage IIIB Hila... Stage IVA Extra... Stage IVA Hilar... Stage IVA Intra... Stage IVB Extra... Stage IVB Hilar... Stage IVB Intra... Unresectable Ex... | Cisplatin Gemcitabine Hyd... Laboratory Biom... Pharmacological... Ricolinostat | 18 Years - | Mayo Clinic | |
Phase 1b Study Evaluating ACY-1215 (Ricolinostat) in Combination With Pomalidomide and Dexamethasone in Relapsed or Relapsed-and-Refractory Multiple Myeloma | NCT02189343 | Multiple Myelom... | ACY-1215 in com... | 18 Years - | Celgene |